ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,265
0,60%
Bitcoin
63 805,99
-0,14%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Xilio Therapeutics Inc (XLO)

  7. Xilio Therapeutics Inc (XLO) Actualités

XLO Xilio Therapeutics Inc

1,1799
0,1299 (12,37%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Xilio Therapeutics Inc XLO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,1299 12,37% 1,1799 06:00:11
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,06 1,04 1,2199 1,18 1,05
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/4/202422:05GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
28/3/202412:05GLOBEXilio Therapeutics Announces $11.3 Million Private Placement..
28/3/202412:00BWGilead and Xilio Announce Exclusive License Agreement for..
28/2/202422:01GLOBEXilio Therapeutics to Participate in Novel Immuno-Oncology..
31/1/202422:01GLOBEXilio Therapeutics to Present at Guggenheim 6th Annual..
19/1/202422:30EDGAR2Form 8-K - Current report
08/1/202413:30GLOBEXilio Therapeutics Highlights Recent Advances Across..
03/1/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:05EDGAR2Form 8-K - Current report
07/12/202313:45EDGAR2Form 8-K - Current report
07/12/202313:30GLOBEXilio Therapeutics Announces Initiation of Enrollment for..
09/11/202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:13EDGAR2Form 8-K - Current report
09/11/202322:10EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
09/11/202322:08EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
09/11/202322:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
09/11/202322:01GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
03/11/202321:05EDGAR2Form 8-K - Current report
03/11/202317:00GLOBEXilio Announces Initial Monotherapy Safety and Anti-Tumor..
31/10/202314:15GLOBEXilio to Host Virtual Investor Conference Call and Webcast..
27/9/202323:02GLOBEXilio Therapeutics Announces Upcoming Presentations at the..
07/9/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202322:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/9/202314:35EDGAR2Form 8-K - Current report
05/9/202314:30GLOBEXilio Therapeutics Announces Promotion of Katarina..
05/9/202313:30GLOBEXilio Therapeutics to Present at Morgan Stanley 21st Annual..
19/8/202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202302:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202313:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:40EDGAR2Form 8-K - Current report
14/8/202313:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
07/8/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202322:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/8/202322:15EDGAR2Form 8-K - Current report
03/8/202322:05GLOBEXilio Therapeutics Announces Promotion of Chris Frankenfield..
25/5/202323:01GLOBEXilio Therapeutics Announces Preliminary Clinical Data from..
09/5/202313:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..

Dernières Valeurs Consultées

NASDAQ
XLO
Xilio Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés